Public Company News
Soundcore Liberty 5: Revolutionizing Voice-Canceling with Adaptive ANC 3.0 and Dolby Audio
Top 3 Global Wireless Audio Brand [1] Unveils Next-Gen Travel-Ready Earbuds HO CHI MINH CITY, Vietnam, May 26, 2025 /PRNewswire/ -- Soundcore, the premium audio brand under Anker Innovations and ranked third globally in wireless headphone shipments, today launched its groundbreaking product, th...
2025-05-26 11:00
2536
Phase 3 Clinical Study of Mazdutide in Chinese Adults with Overweight or Obesity (GLORY-1) Published in The New England Journal of Medicine (NEJM)
SAN FRANCISCO and SUZHOU, China, May 26, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic...
2025-05-26 08:00
3722
EDAN Highlights Commitment to Global Health at GHF 2025 Satellite Symposium, a Side Event of the World Health Assembly
GENEVA, May 25, 2025 /PRNewswire/ -- Edan Instruments, Inc.
2025-05-25 21:41
3377
Mindray Debuts Next-Generation BeneVision V Series Patient Monitoring System at Euroanaesthesia 2025
SHENZHEN, China, May 25, 2025 /PRNewswire/ -- Mindray
2025-05-25 19:00
3460
Soundcore Liberty 5: Revolutionizing Voice-Canceling with Adaptive ANC 3.0 and Dolby Audio
Top 3 Global Wireless Audio Brand[1] Unveils Next-Gen Travel-Ready Earbuds SINGAPORE, May 25, 2025 /PRNewswire/ -- Soundcore, the premium audio brand under Anker Innovations and ranked third globally in wireless headphone shipments, today launched its groundbreaking product, the Liberty 5 in Si...
2025-05-25 14:00
3867
COMPUTEX 2025: MiTAC Powers Sustainable AI Data Centers with New Server & Cooling Tech
TAIPEI, May 24, 2025 /PRNewswire/ -- At COMPUTEX 2025, MiTAC Computing Technology Corp., a subsidiary of MiTAC Holdings Corp. (TWSE: 3706), unveiled its bold new vision: from hardware provider to full-solution AI and data center innovator. With future-ready solutions covering AI training and infe...
2025-05-24 14:52
5850
TWSC Debuts at COMPUTEX 2025: Empowering AI with Full-Stack Storage Solutions
TAIPEI, May 23, 2025 /PRNewswire/ -- From May 20 to 23, 2025, TWSC
2025-05-23 22:08
5790
Tongcheng Travel 2025Q1 Secures Foothold in the Mass Travel Market Revenue Grows 13.2% Yoy to RMB4.4 Billion
Rising Travel Spending Boosts Core OTA Business Growth AI Empowers High-Quality Development Across the Travel Industry Chain HONG KONG, May 23, 2025 /PRNewswire/ -- Tongcheng Travel Holdings Limited ("Tongcheng Travel" or the "Company", together with its subsidiaries the "Group", stock code: 0...
2025-05-23 21:13
7194
NYSE Content Advisory: Pre-Market update + Hinge Health, MNTN pop double digits in trading debuts
NEW YORK, May 23, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Kristen Scholer delivers the pre-market update on May 23rd * Dig...
2025-05-23 20:55
5215
Six Abstracts of Kelun-Biotech's Clinical Studies Published at the 2025 ASCO Annual Meeting
CHENGDU, China, May 23, 2025 /PRNewswire/ -- The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting is scheduled to take place in Chicago, Illinois, USA from May 30 to June 3. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK, the "Company") will present results from six cl...
2025-05-23 17:24
4937
England's NICE recommends FILSPARI® (sparsentan) as a treatment option for IgA nephropathy
First non-immunosuppressive dual-action therapy recommended by NICE for eligible patients with IgA nephropathy, a leading cause of kidney failure1-3 NICE's recommendation is based on clinically meaningful results from the phase-III PROTECT trial4 ST. GALLEN, Switzerland, May 23, 2025 /PRNewswi...
2025-05-23 16:16
4503
Antengene to Present Latest Clinical Results from Two Studies in CPI-resistant Solid Tumors at ASCO 2025
* ATG-037, an oral small molecule CD73 inhibitor, in combination with MSD's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), achieved an overall response rate (ORR) of 36.4% and disease control rate (DCR) of 100% in checkpoint inhibitor (CPI)-resistant melanoma patients in the ongoing STAMINA-01 t...
2025-05-23 12:31
4788
Everest Medicines Announces NEFECON® Inclusion in China's Clinical Practice Guideline for IgA Nephropathy and IgA Vasculitis in Chinese Adults (For Public Review)
SHANGHAI, May 23, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics,announced that NEFECON® has been included in the "Clin...
2025-05-23 11:39
2966
ThunderSoft Showcases Japan-Focused Smart Vehicle Solutions at Automotive Engineering Exposition 2025 Yokohama
YOKOHAMA, Japan, May 22, 2025 /PRNewswire/ -- May 21–23, 2025,ThunderSoft, a global leader in intelligent automotive software, made its debut at the Automotive Engineering Exposition 2025 Yokohama (Booth No. 2-249), presenting its next-generation smart vehicle solutions tailored for the Japanese m...
2025-05-23 10:50
4005
Manhattan Associates Unveils Agentic AI Innovation at Momentum 2025
SYDNEY, May 23, 2025 /PRNewswire/ -- Kicking off Momentum 2025
2025-05-23 10:21
2632
Manulife Shares Responsible AI Principles at Reuters Momentum AI Summit
Jodie Wallis, Global Chief Analytics Officer, Outlines How Manulife is Using AI Responsibly C$ unless otherwise stated TSX/NYSE/PSE: MFC SEHK: 945 TORONTO, May 23, 2025 /PRNewswire/ -- Manulife's Responsible AI Principles were shared during theRe...
2025-05-23 08:00
4309
Binggrae to Expand Presence in Southeast Asia Through Participation in 'THAIFEX 2025'
SEOUL, South Korea, May 23, 2025 /PRNewswire/ -- Binggrae, South Korea's
leading food company, has announced its participation in 'THAIFEX – Anuga Asia
2025,' as part of its broader strategy to expand into Southeast Asian markets.
2025-05-23 08:00
3125
Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) Presented Preclinical Data on GNTbm-38, an Novel Epigenetic Immune Activator, at the 2025 ASCO Annual Meeting
TAIPEI, May 23, 2025 /PRNewswire/ -- GNTbm (stock code: 7427, Taiwan) announced the preclinical data on GNTbm-38, an novel epigenetic immune activator for cancer immunotherapy. GNTbm-38 was presented as posters at the 2025 American Association of Clinical Oncology (ASCO) Annual Meeting, which ...
2025-05-23 08:00
2571
Webull Reports First Quarter 2025 Financial Results
Total revenues grew 32% year-over-year to $117 million, reflecting strong account and trading volume growth Customer assets increased 45% year-over-year, driven by increased customer net deposits Disciplined execution alongside robust revenue growth driving profitability ST. PETERSBURG, Fla....
2025-05-23 04:15
4953
Kavita Kurup Appointed as Chief People Officer of Cyient
HYDERABAD, India and DALLAS, May 22, 2025 /PRNewswire/ -- Cyient Limited, a global Intelligent Engineering solutions company, announced the appointment of Kavita Kurup as Chief People Officer (CPO). Based at the company's Hyderabad headquarters, Kavita will oversee the entire Human Resources func...
2025-05-22 21:30
2089
Week's Top Stories
Most Reposted
Never Miss a Message: Agoda's Customer Support Now Travels With You
[Picked up by 327 media titles]
2026-02-24 12:00
NextFin Asia: A New Dedicated Fund for the Catapult: Inclusion SE Asia Program to Further Scale Inclusive Finance Fintechs in ASEAN
[Picked up by 311 media titles]
2026-02-23 08:00
Amadeus acquires SkyLink to accelerate the deployment of AI in travel
[Picked up by 308 media titles]
2026-02-26 19:57
HBX Group and Traveloka expand strategic partnership to deepen APAC supply and accelerate global distribution
[Picked up by 308 media titles]
2026-02-26 09:30
Klook and Osaka Convention & Tourism Bureau sign MoU to advance inbound tourism and foster socio-economic development throughout Osaka Prefecture
[Picked up by 302 media titles]
2026-02-24 16:13
Most Read
/C O R R E C T I O N -- Republic Power Group Limited (NASDAQ: RPGL)/
2026-02-20 06:36
9480
FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment
2026-02-20 07:27
8694